Canaccord Genuity maintains a 'Buy' on Orexigen Therapeutics (OREX); PDUFA Expected Today
Tweet Send to a Friend
Canaccord Genuity maintains a 'Buy' on Orexigen Therapeutics (NASDAQ: OREX), PT $19.
Canaccord analyst says, "Following the positive Dec. 7 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Canaccord analyst says, "Following the positive Dec. 7 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
